Microcrystalline Calcium Hydroxyapatite (CaHA) powder with particle size range of (35–45 µm) is a structurally stable bioactive ceramic designed for orthopedic, dental, chromatographic, and bioceramic applications. Its larger particle size provides enhanced mechanical stability, lower aggregation tendency, controlled biodegradation, and excellent handling characteristics. This material is commonly used in bone graft substitutes, porous scaffolds, and structural biomaterial systems..
CAT Number: EG-RM- Ca-HAp(µ) - 26
|
PRODUCT INFORMATION |
|
||
|
Structural / Composition Data |
||
|
Structure / Formula |
Ca₁₀(PO₄)₆(OH)₂ |
|
|
Molecular Weight |
502.31g/mol |
|
|
Particle Size (APS) |
35–45 µm |
|
|
Appearance |
White microcrystalline powder |
|
|
Purity |
≥ 99% |
|
|
Morphology |
spherical particles |
|
|
Solubility |
Insoluble in water/dispersible in aqueous systems |
|
|
Form(s) Available |
Dry powder / aqueous dispersion |
|
|
Stability & Shelf Life |
||
|
Storage |
Store at room temperature in dry sealed container |
|
|
Post-Reconstitution |
24 months |
|
|
Stability Notes |
Protect from moisture and contamination |
|
|
Quality & Compliance |
||
|
QC Tests |
|
|
|
Intended Use |
Research, biomaterials, cosmetics, regenerative formulations, bone grafts |
|
|
Documentation |
Certificate of Analysis (CoA), Safety Data Sheet (SDS), Specification Sheet |
|
|
|
|
General Guidance |
Blend uniformly with scaffold or matrix materials. |
|
Recommendations |
Avoid excessive grinding to preserve particle integrity |
|
|
|
Mechanism of Action |
Acts as an osteoconductive scaffold supporting bone cell attachment and gradual mineral exchange. |
|
Biological Claims |
Provides structural support, controlled resorption, and enhanced bone tissue integration. |
|
|
|
Intended Uses |
Bone void fillers, injectable regenerative fillers, orthopedic biomaterials, Dental graft systems, Porous ceramic fabrication. |
|
|||
|
Sizes |
1 kg |
500 g |
|
.
.
.
.
.
.
.
.
.
Because it provides strong structural support and controlled resorption.
CaHA stimulates the production of Type I and Type III collagen, which are essential for skin structure and repair. Type I collagen provides strength and support, while Type III collagen aids in skin regeneration and elasticity.
CaHA injections typically last between 18-24 months, depending on the treatment area, individual factors, and lifestyle. The results are gradual, with long-lasting effects due to collagen stimulation and skin regeneration.
Next-Generation Life Science Products for Everyday Health.